Skip to content
TriangleGet started
← Rectal Cancer

HEALTH PROFESSIONAL · SOURCE READING

First-line immunotherapy

Source: Rectal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: February 12, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Treatment of Stage IV and Recurrent Rectal Cancer / Treatment Options for Stage IV and Recurrent Rectal Cancer / Immunotherapy

Continue within this section

Pembrolizumab monotherapy →Nivolumab and ipilimumab →

Preserved source evidence · Independent clinical review pending · Not medical advice